Literature DB >> 9525671

Mutational analysis of the rous sarcoma virus DR posttranscriptional control element.

R A Ogert1, K L Beemon.   

Abstract

The direct repeat (DR) sequences flanking the src gene in Rous sarcoma virus are essential posttranscriptional control elements; at least one copy of this sequence is necessary for cytoplasmic accumulation of unspliced viral RNA. These sequences promote Rev-independent human immunodeficiency virus type 1 expression, suggesting they act as constitutive transport elements (CTEs). To determine which regions of this sequence are critical for CTE function, mutations in the downstream DR were generated and tested in a viral deletion construct lacking src and the upstream DR. Two single-point mutations and three different clustered mutations caused substantial reductions in reverse transcriptase activity, Gag protein levels, and unspliced viral RNA in the cytoplasm. Three conserved regions of the CTE, including nucleotides 8844 to 8847, 8862 to 8864, and 8868 to 8870, were most sensitive to inactivation by mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525671      PMCID: PMC109836     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA.

Authors:  G F Barker; K Beemon
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

2.  Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein.

Authors:  B K Felber; C M Drysdale; G N Pavlakis
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

5.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

Review 6.  Synthesis and processing of avian sarcoma retrovirus RNA.

Authors:  C M Stoltzfus
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

7.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.

Authors:  M Bray; S Prasad; J W Dubay; E Hunter; K T Jeang; D Rekosh; M L Hammarskjöld
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.

Authors:  S J Arrigo; I S Chen
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

View more
  18 in total

1.  Point mutations in the avian sarcoma/leukosis virus 3' untranslated region result in a packaging defect.

Authors:  J M Aschoff; D Foster; J M Coffin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs.

Authors:  A M Trubetskoy; S A Okenquist; J Lenz
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

4.  Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome.

Authors:  Sergey Smulevitch; Daniel Michalowski; Andrei S Zolotukhin; Ralf Schneider; Jenifer Bear; Patricia Roth; George N Pavlakis; Barbara K Felber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation.

Authors:  Anna Lounková; Eduarda Dráberová; Filip Šenigl; Katerina Trejbalová; Josef Geryk; Jirí Hejnar; Jan Svoboda
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  Nuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5.

Authors:  Andrew W Dangel; Stacey Hull; Tiffiney M Roberts; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Genome structure and expression of the ev/J family of avian endogenous viruses.

Authors:  B L Ruis; S J Benson; K F Conklin
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Selective inhibition of splicing at the avian sarcoma virus src 3' splice site by direct-repeat posttranscriptional cis elements.

Authors:  W Guo; S C Winistorfer; C M Stoltzfus
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  A 205-nucleotide deletion in the 3' untranslated region of avian leukosis virus subgroup J, currently emergent in China, contributes to its pathogenicity.

Authors:  Qi Wang; Yulong Gao; Yongqiang Wang; Liting Qin; Xiaole Qi; Yue Qu; Honglei Gao; Xiaomei Wang
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

10.  A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression.

Authors:  H Wodrich; J Bohne; E Gumz; R Welker; H G Kräusslich
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.